Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics to improve the lives of patients with neurological disorders. The primary functio... Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics to improve the lives of patients with neurological disorders. The primary function of Xenon Pharmaceuticals is to advance its research and development pipeline of targeted treatment candidates, particularly in areas such as epilepsy and rare neurological conditions. The company is distinguished by its strong emphasis on proprietary technologies and its ability to leverage its expertise in ion channel genetics. Xenon Pharmaceuticals impacts the biotechnology sector by contributing to the understanding and treatment of neurological diseases through its scientific advancements. Based in Canada, the company collaborates with global scientific and medical communities to translate their research into clinical success. By addressing niche therapeutic areas with unmet medical needs, Xenon Pharmaceuticals plays a significant role in the biotech industry, working towards providing patients with more effective treatment options.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Xenon Pharmaceuticals is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Xenon Pharmaceuticals is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review Xenon Pharmaceuticals's data?

Start your 30-day free trial to request a data review for Xenon Pharmaceuticals.

Start Free Trial

Legal Center Contact Us